Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System
Toru Ogura, Chihiro Shiraishi
Clinical Drug Investigation (2023) Vol. 43, Iss. 2, pp. 129-140
Closed Access | Times Cited: 11

Showing 11 citing articles:

Approach to Detecting Beneficial and Detrimental Drug-Drug Interactions in Complex Pharmacotherapy
Toru Ogura, Chihiro Shiraishi
Cureus (2025)
Open Access
Drug-induced skin ulcer: real-world pharmacovigilance analysis based on the FDA adverse event reporting system
Qiubai Jin, Jiufei Fang, Feihong Ren, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Comparative Analysis of Adverse Event Profiles Among Seven Statins for Hypercholesterolemia Management Using the United States FDA Adverse Event Reporting System
Toru Ogura, Chihiro Shiraishi
Cureus (2025)
Open Access
Analysis of Adverse Events Following Phenobarbital Administration for Pediatric Patients Categorized by One-Year Age Increments Using the U.S. Food and Drug Administration Adverse Event Reporting System
Toru Ogura, Chihiro Shiraishi
Cureus (2024)
Open Access | Times Cited: 2
Efficacy of Prednisone Avoidance in Patients With Liver Transplant Using the U.S. Food and Drug Administration Adverse Event Reporting System
Toru Ogura, Chihiro Shiraishi
Cureus (2024)
Open Access | Times Cited: 2
Analysis of death avoidance by concomitant use of prednisone in patients with renal transplant using the Food and Drug Administration Adverse Event Reporting System
Toru Ogura, Chihiro Shiraishi, Aiko Urawa
Transplant Immunology (2023) Vol. 80, pp. 101900-101900
Open Access | Times Cited: 5
Proteomic changes related to actin cytoskeleton function in the skin of vildagliptin-treated mice
Antti Nätynki, Nina Kokkonen, Jussi Tuusa, et al.
Journal of Dermatological Science (2024) Vol. 113, Iss. 3, pp. 121-129
Open Access | Times Cited: 1
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
Dehua Zhao, Xiaoqing Long, Jiping Zhou, et al.
Drugs in R&D (2023) Vol. 23, Iss. 4, pp. 403-409
Open Access | Times Cited: 2
Comparison of Adverse Events Following Immunosuppressant Administration for Pediatric Patients With Renal Transplants Categorized by Two-Year Age Increments Using the U.S. Food and Drug Administration Adverse Event Reporting System
Toru Ogura, Chihiro Shiraishi, Yuko Tamura, et al.
Cureus (2024)
Open Access
Comparison of adverse events of poly adenosine diphosphate ribose polymerase inhibitors in patients with ovarian cancer using the united states food and drug administration adverse event reporting system
Toru Ogura, Chihiro Shiraishi
Expert Opinion on Drug Safety (2024)
Closed Access
Prevalence and Predictors of Adverse Events Associated With Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetic Patients: A Cross-sectional Study
Swetha R. Reghunath, Ashna Chackochan, Girish Thunga, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2024) Vol. 17
Open Access
Page 1

Scroll to top